先声药业(02096.HK)：恩泽舒®与恩度®纳入新版国家医保药品目录
SIMCERE PHARMASIMCERE PHARMA(HK:02096) Ge Long Hui·2025-12-07 23:24

Group 1 - The core point of the article is that Xiansheng Pharmaceutical (02096.HK) announced that its drug Enzeshou® (Suvorexant injection) has been officially included in the National Medical Insurance Drug List (2025) by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security, effective from January 1, 2026 [1] - Additionally, the drug Endu® (Recombinant Human Endothelial Inhibitor Injection) has successfully completed the renewal process for the National Medical Insurance Drug List (NRDL) [1]

SIMCERE PHARMA-先声药业(02096.HK)：恩泽舒®与恩度®纳入新版国家医保药品目录 - Reportify